The technological basis underlying Altis Osteogenic Bone Matrix (OBM) are the bone morphogenetic proteins (BMPs), a family of growth factors capable of inducing new bone formation commencing shortly after implantation into human recipients. The company has also developed an injectable delivery system based entirely on bone matrix.
The company also specializes in the purification of type I collagen from porcine bone matrix, which is used as delivery system for porcine BMP complex.
Altis OBM is an implant material intended as an alternative or substitute to traditional bone graft products, which usually involve the harvest of bone from the patient’s own hip, or which employ allograft donor bone supplied by bone tissue banks. Altis OBM is injected into the skeletal site requiring regeneration of new bone, without the need to perform a second bone graft operation. Altis OBM may offer a safe and effective alternative to traditional autogenous grafting procedures still in popular use today.